Document
IPR2017-01913, No. 1069-69 Exhibit - Kern, Role of Angiogenesis in the Transition to Hormone Independence and Acquisition of the Metastatic Phenotype, Endocrinology of Breast Cancer 169 ...
Cite Document
IPR2017-01913, No. 1069-69 Exhibit - Kern, Role of Angiogenesis in the Transition to Hormone Independence and Acquisition of the Metastatic Phenotype, Endocrinology of Breast Cancer 169 86 Manni ed, 1
+ More Snippets
Document
IPR2017-01913, No. 1102-102 Exhibit - Nema, Excipients and Their Use in Injectable Products, 51 PDA J PHARM SCI TECH 166 71 1997 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01913, No. 1102-102 Exhibit - Nema, Excipients and Their Use in Injectable Products, 51 PDA J PHARM SCI TECH 166 71 1997 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01913, No. 1025-25 Exhibit - Caldwell, An Introduction to Drug Disposition The Basic Principles of Absorption, Distribution, Metabolism, and Excretion, 23 Toxicologic Pathology 102 199...
Cite Document
IPR2017-01913, No. 1025-25 Exhibit - Caldwell, An Introduction to Drug Disposition The Basic Principles of Absorption, Distribution, Metabolism, and Excretion, 23 Toxicologic Pathology 102 1995 (P.T.A
+ More Snippets
Document
IPR2017-01913, No. 1030-30 Exhibit - White, Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose Optimization, 57 ANTIMICROBIAL AGENTS CHEMOTHERAPY 5802 2...
Cite Document
IPR2017-01913, No. 1030-30 Exhibit - White, Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose Optimization, 57 ANTIMICROBIAL AGENTS CHEMOTHERAPY 5802 2013 (P.T.A.B. Aug. 4, 2017
+ More Snippets
Document
IPR2017-01913, No. 2102-216 Exhibit - Ansel Ch 10 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2102-216 Exhibit - Ansel Ch 10 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2126-240 Exhibit - PDR 1999 Arimidex (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2126-240 Exhibit - PDR 1999 Arimidex (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2039-153 Exhibit - Hayes 1995 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2039-153 Exhibit - Hayes 1995 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 1085-85 Exhibit - Goldenberg, Trastuzumab, a Recombinant DNA Derived Humanized Monoclonal Antibody, a Novel Agent for the Treatment of Metastatic Breast Cancer, 21...
Cite Document
IPR2017-01913, No. 1085-85 Exhibit - Goldenberg, Trastuzumab, a Recombinant DNA Derived Humanized Monoclonal Antibody, a Novel Agent for the Treatment of Metastatic Breast Cancer, 21 CLINICAL THERAPEU
+ More Snippets
Document
IPR2017-01913, No. 1088-88 Exhibit - Wunsche, Estrogenic Regulation of Clusterin mRNA in Normal and Malignant Endometrial Tissue, 76 INT J CANCER 684 88 1998 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01913, No. 1088-88 Exhibit - Wunsche, Estrogenic Regulation of Clusterin mRNA in Normal and Malignant Endometrial Tissue, 76 INT J CANCER 684 88 1998 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01913, No. 1108-108 Exhibit - Sawka, Physiological Consequences of Hypohydration Exercise Performance and Thermoregulation, 24 MEDICINE SCIENCE IN SPORTS EXERCISE 65...
Cite Document
IPR2017-01913, No. 1108-108 Exhibit - Sawka, Physiological Consequences of Hypohydration Exercise Performance and Thermoregulation, 24 MEDICINE SCIENCE IN SPORTS EXERCISE 657 70 1992 (P.T.A.B. Aug.
+ More Snippets
Document
IPR2017-01913, No. 1063-63 Exhibit - Equivalent Surface Area Dosage Conversion Factors 2007 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01913, No. 1063-63 Exhibit - Equivalent Surface Area Dosage Conversion Factors 2007 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2076-190 Exhibit - Agrawal 2009 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2076-190 Exhibit - Agrawal 2009 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2105-219 Exhibit - Porras 1999 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2105-219 Exhibit - Porras 1999 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 1091-91 Exhibit - Ansel, Dosage Form Design Biopharmaceutic and Pharmacokinetic Considerations, Pharmaceutical Dosage Forms and Drug Delivery Systems 101 41 7th...
Cite Document
IPR2017-01913, No. 1091-91 Exhibit - Ansel, Dosage Form Design Biopharmaceutic and Pharmacokinetic Considerations, Pharmaceutical Dosage Forms and Drug Delivery Systems 101 41 7th ed 1999 (P.T.A.B. Au
+ More Snippets
Document
IPR2017-01913, No. 1051-51 Exhibit - Howell, New Endocrine Therapies for Breast Cancer, 32A EUR J CANCER 576 88 1996 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01913, No. 1051-51 Exhibit - Howell, New Endocrine Therapies for Breast Cancer, 32A EUR J CANCER 576 88 1996 (P.T.A.B. Aug. 4, 2017)
+ More Snippets